Developing electronic-nose technologies for clinical practice
The development of relatively simple gas-sensing devices with sensor arrays capable of constructing molecular profiles of complex Volatile Organic Compound (VOC) metabolites from clinical samples, based on production of healthy or disease-specific digital signature patterns, may soon help to revolutionize diagnostic procedures in clinical practice. This mini-review summarizes the development of recent portable electronic-nose (e-nose) technologies as new diagnostic tools with the potential for accelerating clinical procedures to facilitate non-invasive early disease diagnoses, improving the speed and accuracy of Point-Of-Care Testing (POCT); yielding more effective treatments and significantly improving prognoses.
Requesting Print Publications
Publication requests are subject to availability. Fiscal responsibility limits the hardcopies of publications we produce and distribute. Electronic versions of publications may be downloaded, distributed and printed.
Please make any requests at firstname.lastname@example.org.
- This article was written and prepared by U.S. Government employees on official time, and is therefore in the public domain.
- Our online publications are scanned and captured using Adobe Acrobat. During the capture process some typographical errors may occur. Please contact the SRS webmaster if you notice any errors which make this publication unusable.
- To view this article, download the latest version of Adobe Acrobat Reader.